Copyright
©The Author(s) 2016.
World J Clin Urol. Mar 24, 2016; 5(1): 53-59
Published online Mar 24, 2016. doi: 10.5410/wjcu.v5.i1.53
Published online Mar 24, 2016. doi: 10.5410/wjcu.v5.i1.53
Normal Weight(BMI 18.5-24.9) | Underweight(BMI < 18.5) | Overweight(BMI 25.0-29.9) | Obese(BMI > 30) | P value | ||
Age at surgery (median, IQR), yr | 70 (63-76) | 78 (68-79) | 70 (61-76) | 67 (58-72) | 0.126 | |
Gender | Male | 74 (66%) | 4 (44%) | 130 (81%) | 106 (75%) | 0.005 |
Female | 39 (35%) | 5 (56%) | 30 (19%) | 36 (25%) | ||
Clinical tumor stage | cT0 | 1 (1%) | 0 (0%) | 1 (1%) | 1 (1%) | 0.05 |
cTis | 0 (0%) | 0 (0%) | 8 (5%) | 11 (8%) | ||
cTa | 7 (7%) | 1 (11%) | 9 (6%) | 10 (8%) | ||
cT1 | 30 (28%) | 2 (22%) | 26 (17%) | 35 (26%) | ||
cT2 | 65 (61%) | 4 (44%) | 103 (67%) | 67 (50%) | ||
cT3 | 3 (3%) | 2 (22%) | 4 (3%) | 5 (4%) | ||
cT4 | 1 (1%) | 0 (0%) | 3 (2%) | 4 (3%) | ||
Prior intravesical therapy | No | 86 (78%) | 6 (67%) | 113 (71%) | 83 (59%) | 0.018 |
Yes | 25 (22%) | 3 (33%) | 47 (29%) | 57 (41%) | ||
Prior neoadjuvant chemotherapy | No | 100 (90%) | 9 (100%) | 150 (94%) | 129 (92%) | 0.478 |
Yes | 11 (10%) | 0 (0%) | 9 (6%) | 11 (8%) | ||
Race | Caucasian | 105 (92%) | 9 (100%) | 151 (94%) | 134 (94%) | 0.492 |
Hispanic | 3 (3%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
Black | 3 (3%) | 0 (0%) | 6 (4%) | 7 (5%) | ||
Asian | 1 (1%) | 0 (0%) | 2 (1%) | 0 (0%) | ||
Unknown | 1 (1%) | 0 (0%) | 1 (1%) | 1 (1%) | ||
Hypertension | No | 52 (46%) | 2 (22%) | 73 (46%) | 33 (23%) | < 0.001 |
Yes | 60 (54%) | 7 (78%) | 87 (54%) | 108 (77%) | ||
Diabetes mellitus, type II | No | 99 (88%) | 8 (89%) | 132 (82%) | 100 (71%) | 0.006 |
Yes | 13 (12%) | 1 (11%) | 28 (18%) | 40 (29%) | ||
Coronary artery disease | No | 89 (80%) | 9 (100%) | 125 (78%) | 103 (74%) | 0.248 |
Yes | 23 (20%) | 0 (0%) | 35 (22%) | 37 (26%) | ||
Cardiac arrhythmia | No | 102 (91%) | 7 (78%) | 143 (89%) | 129 (92%) | 0.491 |
Yes | 10 (9%) | 2 (22%) | 17 (11%) | 11 (8%) | ||
History of coronary vascular accident | No | 106 (95%) | 8 (89%) | 156 (97%) | 139 (99%) | 0.068 |
Yes | 6 (5%) | 1 (11%) | 4 (3%) | 1 (1%) | ||
Pulmonary disease | No | 94 (84%) | 7 (78%) | 147 (92%) | 115 (82%) | 0.063 |
Yes | 18 (16%) | 2 (22%) | 13 (8%) | 25 (18%) | ||
Liver disease | No | 110 (98%) | 8 (89%) | 159 (99%) | 138 (99%) | 0.077 |
Yes | 2 (2%) | 1 (11%) | 1 (1%) | 1 (1%) | ||
Nephrolithiasis | No | 101 (91%) | 9 (100%) | 149 (93%) | 126 (90%) | 0.606 |
Yes | 10 (9%) | 0 (0%) | 11 (7%) | 14 (10%) | ||
Preoperative renal function | Normal | 58 (72%) | 7 (88%) | 79 (70%) | 70 (71%) | 0.652 |
CKD stage 3 | 19 (24%) | 1 (12%) | 31 (28%) | 26 (27%) | ||
CKD stage 4 | 2 (2%) | 0 (0%) | 2 (2%) | 2 (2%) | ||
CKD stage 5 | 2 (2%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
Smoking history | No | 27 (24%) | 1 (11%) | 42 (27%) | 36 (26%) | 0.76 |
Yes | 84 (76%) | 8 (89%) | 116 (73%) | 103 (74%) |
- Citation: Burge BK, Blackwell RH, Wilson A, Flanigan RC, Gupta GN, Quek ML. Perioperative outcomes and survival of radical cystectomy as a function of body mass index. World J Clin Urol 2016; 5(1): 53-59
- URL: https://www.wjgnet.com/2219-2816/full/v5/i1/53.htm
- DOI: https://dx.doi.org/10.5410/wjcu.v5.i1.53